Cargando…

COVID-19 in people with rheumatic diseases: risks, outcomes, treatment considerations

The COVID-19 pandemic has brought challenges for people with rheumatic disease in addition to those faced by the general population, including concerns about higher risks of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and poor outcomes of COVID-19. The data that are n...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grainger, Rebecca, Kim, Alfred H. J., Conway, Richard, Yazdany, Jinoos, Robinson, Philip C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8874732/ https://www.ncbi.nlm.nih.gov/pubmed/35217850 http://dx.doi.org/10.1038/s41584-022-00755-x

Ejemplares similares

Racial and ethnic differences in COVID-19 outcomes: a call to action
por: Robinson, Philip C, et al.
Publicado: (2022)

Novel coronavirus disease-2019 (COVID-19) in people with rheumatic disease: Epidemiology and outcomes
por: Grainger, Rebecca, et al.
Publicado: (2021)

The COVID-19 Global Rheumatology Alliance: collecting data in a pandemic
por: Robinson, Philip C., et al.
Publicado: (2020)

Peer Support in Rheumatic Diseases: A Narrative Literature Review
por: Karp, Nathan, et al.
Publicado: (2023)

Rheumatic disease and COVID-19: initial data from the COVID-19 Global Rheumatology Alliance provider registries
por: Gianfrancesco, Milena A, et al.
Publicado: (2020)

Inflammatory arthritis in patients with COVID-19
por: Conway, Richard, et al.
Publicado: (2021)

Outcomes of COVID-19 in people with rheumatic and musculoskeletal disease in Ireland over the first 2 years of the pandemic
por: Conway, Richard, et al.
Publicado: (2023)

Temporal trends in COVID-19 outcomes in people with rheumatic diseases in Ireland: data from the COVID-19 Global Rheumatology Alliance registry
por: Conway, Richard, et al.
Publicado: (2022)

Factors Associated With Hospitalization and Death After COVID‐19 Diagnosis Among Patients With Rheumatic Disease: An Analysis of Veterans Affairs Data
por: Schmajuk, Gabriela, et al.
Publicado: (2021)

Immediate effect of the COVID-19 pandemic on patient health, health-care use, and behaviours: results from an international survey of people with rheumatic diseases
por: Hausmann, Jonathan S, et al.
Publicado: (2021)

Challenges in understanding the role of pregnancy morbidity in cardiovascular risk in SLE
por: Simard, Julia F, et al.
Publicado: (2014)

Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry
por: Strangfeld, Anja, et al.
Publicado: (2021)

Patient-Centered Outcomes Research Institute (PCORI) multisite project to develop treatment decision aids for racial/ethnic minorities with lupus nephritis
por: Yazdany, Jinoos, et al.
Publicado: (2014)

Practical Considerations for Developing Clinical Natural Language Processing Systems for Population Health Management and Measurement
por: Tamang, Suzanne, et al.
Publicado: (2023)

Prolonged COVID-19 symptom duration in people with systemic autoimmune rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey
por: DiIorio, Michael, et al.
Publicado: (2022)

Omicron variant infection in inflammatory rheumatological conditions – outcomes from a COVID-19 naive population in Aotearoa New Zealand
por: Brooks, Jonathon, et al.
Publicado: (2023)

Risks of mortality and severe coronavirus disease 19 (COVID-19) outcomes in patients with or without systemic lupus erythematosus
por: Bruera, Sebastian, et al.
Publicado: (2023)

Characteristics and Outcomes of People With Gout Hospitalized Due to COVID‐19: Data From the COVID‐19 Global Rheumatology Alliance Physician‐Reported Registry
por: Jatuworapruk, Kanon, et al.
Publicado: (2022)

Patient-reported outcome measures for use in clinical trials of SLE: a review
por: Izadi, Zara, et al.
Publicado: (2018)

Environmental and societal factors associated with COVID-19-related death in people with rheumatic disease: an observational study
por: Izadi, Zara, et al.
Publicado: (2022)

The impact of COVID-19 on rheumatology training—results from the COVID-19 Global Rheumatology Alliance trainee survey
por: Young, Kristen, et al.
Publicado: (2022)

Type I interferon, anti-interferon antibodies, and COVID-19
por: Calabrese, Leonard H, et al.
Publicado: (2021)

Are patient ratings of interactions with providers and health plans associated with technical quality of care in systemic lupus erythematosus?
por: Yelin, Edward, et al.
Publicado: (2014)

Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey
por: Sattui, Sebastian Eduardo, et al.
Publicado: (2021)

Predictors of hospitalization in patients with rheumatic disease and COVID-19 in Ireland: data from the COVID-19 global rheumatology alliance registry
por: Conway, Richard, et al.
Publicado: (2021)

Rapid Adoption of Telemedicine in Rheumatology Care During the COVID‐19 Pandemic Highlights Training and Supervision Concerns Among Rheumatology Trainees
por: Yeoh, Su‐Ann, et al.
Publicado: (2021)

The racial/ethnic and sociocultural aspects of the pandemic in rheumatology
por: Taylor, Tiffany, et al.
Publicado: (2021)

Changing COVID-19 outcomes in patients with rheumatic disease—are we really getting better at this?
por: Gianfrancesco, Milena A, et al.
Publicado: (2021)

Minorities with lupus nephritis and medications: a study of facilitators to medication decision-making
por: Singh, Jasvinder A., et al.
Publicado: (2015)

Comorbidities in rheumatic diseases need special consideration during the COVID-19 pandemic
por: Ahmed, Sakir, et al.
Publicado: (2021)

Antimalarial drugs—are they beneficial in rheumatic and viral diseases?—considerations in COVID-19 pandemic
por: Grygiel-Górniak, Bogna
Publicado: (2021)

A Pharmacokinetics‐Informed Approach to Navigating Hydroxychloroquine Shortages in Patients With Rheumatic Disease During the COVID‐19 Pandemic
por: Scheetz, Marc H., et al.
Publicado: (2020)

Addressing the challenges of the SARS-CoV-2 pandemic in patients affected by autoimmune and rheumatic disease
por: Robinson, Philip C., et al.
Publicado: (2021)

SARS-CoV-2 breakthrough infections among vaccinated individuals with rheumatic disease: results from the COVID-19 Global Rheumatology Alliance provider registry
por: Liew, Jean, et al.
Publicado: (2022)

Implementation of disease activity measurement for rheumatoid arthritis patients in an academic rheumatology clinic
por: Bays, Alison, et al.
Publicado: (2016)

Assessment of Evidence for COVID-19 and Rheumatic Diseases: Brief Considerations about Immunity and Pathophysiology
por: Jadali, Zohreh
Publicado: (2021)

Reactivation of hepatitis B virus infection in rheumatic diseases: risk and management considerations
por: Koutsianas, Christos, et al.
Publicado: (2020)

COVID-19, chronic inflammatory rheumatic disease and anti-rheumatic treatments
por: Ouédraogo, Dieu-Donné, et al.
Publicado: (2020)

Extraarticular Manifestations of Rheumatoid Arthritis in a Multiethnic Cohort of Predominantly Hispanic and Asian Patients
por: Richman, Nicole C., et al.
Publicado: (2013)

Approaches for estimating minimal clinically important differences in systemic lupus erythematosus
por: Rai, Sharan K, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_n6naqjbdduatdv7ja5ieascin1